Replacing Mycophenolate Mofetil by Everolimus to Increase Vaccine Immunogenicity in Kidney Transplant Recipients: A Randomized Controlled Trial

Switching transplant patients from mycophenolate to everolimus did not improve their COVID-19 booster response but did improve their shingles-vaccine antibodies, while causing more bacterial infections.